Federated Hermes
TERN

Federated Hermes’s Terns Pharmaceuticals TERN Stock Holding History

Federated Hermes’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.9K Buy
719
+550
+325% +$22.6K ﹤0.01% 1708
2025
Q4 		$6.83K Buy
+169
New +$3.91K ﹤0.01% 1866
2025
Q2 		– Sell
-225
Closed -$621 – 2184
2025
Q1 		$621 Sell
225
-558
-71% -$2.28K ﹤0.01% 2017
2024
Q4 		$4.34K Buy
783
+300
+62% +$2.03K ﹤0.01% 1909
2024
Q3 		$4.03K Sell
483
-733
-60% -$6.03K ﹤0.01% 1876
2024
Q2 		$8.28K Buy
+1,216
New +$7.37K ﹤0.01% 1797
2023
Q3 		– Sell
-168
Closed -$1.47K – 2196
2023
Q2 		$1.47K Buy
+168
New +$1.96K ﹤0.01% 2010

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Federated Hermes's TERN Position: Q1 2026 in Review

Federated Hermes increased its Terns Pharmaceuticals (TERN) stake by 325% in Q1 2026, buying an estimated $22.6K and bringing the position to 719 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Federated Hermes first reported a position in TERN in Q2 2023 and has held it in 7 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Federated Hermes held 719 shares of Terns Pharmaceuticals worth $37.9K as of Q1 2026.
  • Federated Hermes bought 550 Terns Pharmaceuticals shares in Q1 2026, an estimated $22.6K.
  • Terns Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1708 holding.
  • Federated Hermes first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.